Global Pharmaceuticals & Biotech Breakout Stocks

Insmed

Market Cap: US$29.0b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Pharmaron Beijing

Market Cap: CN¥79.7b

Operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally.

Halozyme Therapeutics

Market Cap: US$11.6b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally.

Praxis Precision Medicines

Market Cap: US$10.3b

A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$60.0b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

10x Genomics

Market Cap: US$7.6b

Develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.

Genscript Biotech

Market Cap: HK$54.4b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

MGI Tech

Market Cap: CN¥26.4b

Engages in the research, development, production, and sale of instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally.

Harbin Pharmaceutical Group

Market Cap: CN¥22.2b

Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.

AbCellera Biologics

Market Cap: US$3.0b

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

Shanghai Haoyuan Chemexpress

Market Cap: CN¥20.1b

Engages in the research, development, and manufacture of pharmaceutical intermediates and small molecule drugs.

Iovance Biotherapeutics

Market Cap: US$2.9b

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally.

GemPharmatech

Market Cap: CN¥15.8b

A contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide.

HitGen

Market Cap: CN¥15.2b

Operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally.

Septerna

Market Cap: US$2.2b

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

Sino BiologicalInc

Market Cap: CN¥14.1b

Engages in the provision of recombinant protein and antibody reagents for life science researchers in China and internationally.

Shanghai Medicilon

Market Cap: CN¥13.9b

A contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally.

AcrobiosystemsLtd

Market Cap: CN¥13.7b

Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.

Shanghai InnoStar Bio-tech

Market Cap: CN¥13.0b

Provides drug research and development services in China and internationally.

Nanjing Vazyme Biotech

Market Cap: CN¥12.2b

Offers technology solutions for life science, biomedicine, and in vitro diagnostics.

PharmaBlock Sciences (Nanjing)

Market Cap: CN¥11.5b

Provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally.

HBM Holdings

Market Cap: HK$13.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

Replimune Group

Market Cap: US$1.3b

A clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer in the United States and the United Kingdom.

Shanghai OPM Biosciences

Market Cap: CN¥8.6b

Provides cell culture media and CDMO services in China and internationally.

HARBIN GLORIA PHARMACEUTICALS

Market Cap: CN¥8.6b

Engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally.

PharmaResources (Shanghai)

Market Cap: CN¥7.1b

Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.

Bide Pharmatech

Market Cap: CN¥6.9b

Engages in the research, development, production, and sale of drug molecule building blocks and scientific reagents in China.

Anhui Wanbang Pharmaceutical TechnologyLtd

Market Cap: CN¥6.9b

Anhui Wanbang Pharmaceutical Technology Co.,Ltd.

Novogene

Market Cap: CN¥6.5b

Provides genomic services and solutions in Mainland China, Hong Kong, Macau, Taiwan, and internationally.

GlaxoSmithKlineE

Market Cap: ج.م45.9b

Engages in production of pharmaceutical chemicals.

R&G PharmaStudies

Market Cap: CN¥6.1b

Operates as a clinical trial outsourcing service provider in China and internationally.

Aarti Pharmalabs

Market Cap: ₹80.6b

Manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally.

Xinjiang Bai Hua Cun Pharma TechLtd

Market Cap: CN¥5.4b

Engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses.

Sichuan Goldstone Asia Pharmaceutical

Market Cap: CN¥4.8b

Sichuan Goldstone Asia Pharmaceutical Inc.

Gansu Longshenrongfa Pharmaceutical IndustryLTD

Market Cap: CN¥4.8b

Researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally.

Silence Therapeutics

Market Cap: US$695.3m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.